logo
Select company
Select metric
$ -41.45MConsolidated Income
VS
Market
21
Sector
42
Industry
38
History
5
$ 0.53Close
$ 0.24 - $ 2.44 52-Week Range
Ticker Information

Ticker

PRPH

Company Name

PROPHASE LABS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PROPHASE LABS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRPH - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -41.45M
3/31/2025$ -43.13M
12/31/2024$ -53.36M
9/30/2024$ -27.76M
6/30/2024$ -26.31M
3/31/2024$ -23.6M
12/31/2023$ -16.78M
9/30/2023$ -10.47M
6/30/2023$ -4.37M
3/31/2023$ 6.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROPHASE LABS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -1.61M.
  • Over the past 5 years, PROPHASE LABS INC's average Cons. Inc. has been $ -7.56M.
  • The median Cons. Inc. for PROPHASE LABS INC during this period was $ -3.25M
  • PROPHASE LABS INC reached its highest Cons. Inc. over the past 5 years at $ 31.5M.
  • The lowest Cons. Inc. recorded by PROPHASE LABS INC in the same timeframe $ -53.36M

PROPHASE LABS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
BNBX : APPLIED DNA SCIENCES INC $ -13.3MINBS : INTELLIGENT BIO SOLUTIONS INC $ -10.6MTNON : TENON MEDICAL INC $ -12.66MTRAW : TRAWS PHARMA INC $ -17.82MTXMD : THERAPEUTICSMD INC $ -459KLGVN : LONGEVERON INC $ -18.54MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MLPCN : LIPOCINE INC $ -4.51MCYCN : CYCLERION THERAPEUTICS INC $ -1.95MXAIR : BEYOND AIR INC $ -43.5M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

PRPH - Consolidated Income, Last 5 years

$ -53.36M

Minimum

Dec 31, 2024

$ 31.5M

Maximum

Sep 30, 2022

$ -7.56M

Average

$ -3.25M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M